Tango Therapeutics
TNGX • NASDAQ
Tango Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Malte Peters, with a market cap of $4.0B.
Market Cap$4.0B
Employees140.0
CEOMalte Peters
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
TNG
Tango Therapeutics FAQ
Common questions about Tango Therapeutics
Tango Therapeutics is scheduled to report earnings for Q1 2026 on May 11, 2026 before market open. Analysts estimate revenue of $578.1K.
Tango Therapeutics has approximately 140 employees.